Skip to main content
. 2019 Apr 17;70(5):754–762. doi: 10.1093/cid/ciz318

Table 4.

Cost-effectiveness of Clostridioides difficile Infection Treatment Strategies

Strategy No. Nonsevere Severe First Recurrence Second or Later Recurrence Cost Incremental Cost Effectiveness, QALYs Incremental Effectiveness, QALYs ICER, $/QALY
3 Metronidazole Vancomycin Vancomycin Vancomycin $64 509 12.280
1 Vancomycin Vancomycin Vancomycin Vancomycin $64 692 $183 12.352 0.072 2537
25 Vancomycin Vancomycin Vancomycin Vancomycin + rifaximin $64 917 $225 12.406 0.054 4208
37 Vancomycin Vancomycin Vancomycin FMT $65 125 $208 12.426 0.020 10 383
43 Vancomycin Vancomycin Fidaxomicin FMT $65 411 $286 12.442 0.016 27 428
44 Fidaxomicin Vancomycin Fidaxomicin FMT $65 889 $478 12.451 0.009 31 751

All costs are given as US dollars.

Abbreviations: FMT, fecal microbiota transplantation; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-year.